SCHEMBL30262185

CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR1	P32241	4/20	0.57

▸	VIPR2	P41587	6/20	0.54

▸	TFPI	P10646	1/20	0.54

▸	GLP1R	P43220	2/20	0.52

▸	ECE1	P42892	1/20	0.52

▸	MUS81	Q96NY9	1/20	0.52

▸	RXFP1	Q9HBX9	1/20	0.52

▸	PTH1R	Q03431	1/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29623995	0.95	VIPR1 (0.61)	VIPR1VIPR2TFPIGLP1RECE1
SCHEMBL29677217	0.95	VIPR2 (0.57)	VIPR1VIPR2TFPIGLP1RECE1
SCHEMBL29677265	0.92	VIPR2 (0.57)	VIPR1VIPR2TFPIGLP1RECE1
SCHEMBL30176490	0.92	VIPR1 (0.57)	VIPR1VIPR2TFPIGLP1RECE1
SCHEMBL30432139	0.91	RXFP1 (0.58)	VIPR1TFPIGLP1RRXFP1PTH1R
SCHEMBL30576940	0.91	RXFP1 (0.55)	VIPR1VIPR2TFPIGLP1RECE1
SCHEMBL31603938	0.90	VIPR1 (0.58)	VIPR1VIPR2TFPIGLP1RECE1
SCHEMBL29378778	0.90	GLP1R (0.52)	VIPR1VIPR2TFPIGLP1R
SCHEMBL30862319	0.90	RXFP1 (0.57)	VIPR1TFPIGLP1RECE1MUS81
SCHEMBL29624007	0.90	VIPR2 (0.52)	VIPR1VIPR2TFPIGLP1RECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230040544-A1	COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC)	SAREPTA THERAPEUTICS, INC.	2023-02-09	—	—	US	disclosed